CENTRIC HEALTH (CHH) Stock Price Up 0%

CENTRIC HEALTH Corp (TSE:CHH) rose 0% on Wednesday . The stock traded as high as C$0.55 and last traded at C$0.53. Approximately 106,221 shares changed hands during mid-day trading, a decline of 72% from the average daily volume of 380,814 shares. The stock had previously closed at C$0.53.

CHH has been the subject of several recent research reports. National Bank Financial decreased their price target on CENTRIC HEALTH from C$0.80 to C$0.75 in a research note on Thursday, November 16th. Canaccord Genuity decreased their price target on CENTRIC HEALTH from C$1.20 to C$1.10 in a research note on Thursday, November 16th.

In related news, insider Josephine Antonia Deslauriers purchased 150,000 shares of the firm’s stock in a transaction dated Friday, December 8th. The stock was bought at an average price of C$0.50 per share, with a total value of C$75,000.00.

COPYRIGHT VIOLATION WARNING: This article was first reported by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are accessing this article on another site, it was stolen and reposted in violation of US & international copyright & trademark law. The legal version of this article can be viewed at https://www.dispatchtribunal.com/2017/12/22/centric-health-chh-stock-price-up-0-2.html.


Centric Health Corp is a Canada-based company primarily engaged in the drug retail sector. The Company’s activities are divided into two business segments: Specialty Pharmacy, as well as Surgical and Medical Centers. The Specialty Pharmacy division focuses on the drug retail and wholesale through pharmacies and fulfillment locations, as well as it offers additional drug-relates services, such as compounding and dispensing medications, advisory, addiction management and specialty services for long-term care and retirement facilities.

Receive News & Ratings for CENTRIC HEALTH Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CENTRIC HEALTH and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply